ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $751,355 | -34.8% | 124,191 | -16.4% | 0.00% | – |
| Q2 2023 | $1,152,989 | +115.1% | 148,581 | +58.0% | 0.00% | – |
| Q1 2023 | $535,965 | +58.0% | 94,029 | +63.3% | 0.00% | – |
| Q4 2022 | $339,118 | +180.3% | 57,575 | +52.8% | 0.00% | – |
| Q3 2022 | $121,000 | -65.8% | 37,690 | -52.4% | 0.00% | – |
| Q2 2022 | $354,000 | -9.5% | 79,203 | +8.2% | 0.00% | – |
| Q1 2022 | $391,000 | -42.6% | 73,197 | +57.9% | 0.00% | – |
| Q4 2021 | $681,000 | +72.0% | 46,367 | +145.1% | 0.00% | – |
| Q3 2021 | $396,000 | -84.7% | 18,914 | -87.0% | 0.00% | – |
| Q2 2021 | $2,582,000 | +717.1% | 146,015 | +1033.2% | 0.00% | – |
| Q1 2021 | $316,000 | -70.1% | 12,885 | -58.7% | 0.00% | – |
| Q4 2020 | $1,056,000 | +4491.3% | 31,209 | +3223.6% | 0.00% | – |
| Q3 2020 | $23,000 | -76.0% | 939 | -67.1% | 0.00% | – |
| Q2 2020 | $96,000 | – | 2,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |